OKTA vs VNRX · P/E 84, rev $1.57B vs rev $1.4M
Okta Inc (OKTA) versus Volitionrx Ltd (VNRX) — a side-by-side from cached financials, not a winner call.
Okta Inc (OKTA) is a software - infrastructure company listed on NASDAQ.
Volitionrx Ltd (VNRX) is a medical devices company listed on AMEX.
Latest reported OKTA revenue for 2026-07-31 was $1.57B. Net income was $190.0M. OKTA currently screens at market cap $20.06B and trailing P/E 83.6.
Latest reported VNRX revenue for 2026-06-30 was $1.4M. Net income was -$14.0M. Revenue was up 40.5% from 2026-03-31 to 2026-06-30. VNRX currently screens at market cap $15.9M.
OKTA currently screens at market cap $20.06B and trailing P/E 83.6. VNRX currently screens at market cap $15.9M.
Not investment advice. Open the OKTA and VNRX stock pages for the full models.
Not investment advice.